Please login to the form below
pricing
This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.
Is Orkambi deal close? Vertex meets again today with NHS England
NHS England went public last summer with its own five-year £500m pricing deal for Orkambi and Vertex’s other CF treatments Kalydeco and Symkevi, the latest addition to its portfolio.
Latest news
-
NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
industry. Recent examples of this include rapid pricing deals on the two CAR-T therapies, Novartis’ Kymriah and Gilead’s Yescarta. ... This is seen by both sides as a formality, which allows the next stage of pricing and access talks to begin – but
-
Roche gets EU nod for much-expanded Hemlibra label
of patients with inhibitors, and was fuelled by competitive pricing compared to factor VIII replacement.
-
Optimism on Orkambi in England as talks to resume
Nevertheless, they also expressed willingness to resume talks in good faith, despite trust having broken down after both sides traded accusations, and NHS England broke protocol by spelling out its pricing ... The pressure is now particularly on NHS
-
Trump budget targets rebates, out-of-pocket costs
Away from drug pricing, the budget includes an increase in funding for HIV programmes, a 12.6% drop in funding for the National Institutes of Health (NIH) which is likely to
-
NHS England’s medicines chief: stop ‘salami slicing’ and get faster market access
Late last year, NHS England went one step further to develop its pricing and reimbursement expertise and appointed Blake Dark, an experienced pharma industry executive, as the new head of its
More from news
Approximately 90 fully matching, plus 804 partially matching documents found.
Latest Intelligence
-
Drug launches to watch in 2019
also looking to lead the revolution in pricing and reimbursement required to make them a commercial success.
-
The UK’s new five-year pricing agreement
The UK has a new five-year Voluntary Pricing and Access Scheme (VPAS) for branded medicines, which came into force on 1 January 2019. ... Read the full 2019 Voluntary Scheme for Branded Medicines Pricing and Access document here.
-
Escaping the spin cycle of sub-optimal launch
Furthermore, as downward pressure on pricing intensifies, algorithmic prescribing management is redefining the dynamics of customer engagement.
-
Is China ready for a pharmaceutical gold rush?
Innovent Biologics Inc raised HK$3.3bn ($421m) at a valuation of $2bn when its shares closed at the upper end of its pricing range on 24 October 2018.
-
Combined immunotherapies – potential and pitfalls
Economics. Developers willing to take on the additional challenges of trialling a combination immunotherapy need to keep pricing in mind.
More from intelligence
Approximately 16 fully matching, plus 149 partially matching documents found.
Latest appointments
-
New faces at imc, GCI Health and Lighthouse US
leadership, with an emphasis on issues related to access, value and pricing.
-
New faces at GCI Health, Porterhouse Medical and Research Partnership
Meanwhile Emma Warburton joins the agency as business development executive after previously working as a pricing and market research analyst.
-
BMS appoints new commercial leader, Davies joins Eisai and more
She will also oversee marketing, pricing, forecasting and analytics. Brian Hoffmann, president of Hikma’s generics division, said: “I am looking forward to working closely with Kristy and her team to
-
Weekly comms appointments
Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and
-
Claes Buxfeldt joins NDA
He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.
More from appointments
Approximately 2 fully matching, plus 30 partially matching documents found.
Latest from PMHub
-
New appointments in our UK and New York offices
She studied International Politics at City, University of London. Emma has previous experience working as a pricing and market research analyst.
-
GCI Health hires Kim Walker as Deputy Managing Director in London
environment. With a deep focus on multi-channel marketing, including media relations and digital communications, storytelling, consumer and patient engagement and activations, scientific communications, access and pricing, corporate communications,
-
Achieve up to 80% auto-population of your first draft HTA submission
pricing, reimbursement &market access. CLIENT SITUATION. A top-5 global pharma company investigated digital solutions from various companies to improve the quality and development timelines of multiple simultaneous HTA submissions.
-
PR-it
PR-it combines the power of a global community of high-calibre, seasoned public relations, digital and creative experts with a proprietary data-driven pricing model.
-
PRMA Consulting Ltd
PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international pharmaceutical and biotechnology companies today. ... Our tailored services include strategic market
More from PMHub
Approximately 6 fully matching, plus 49 partially matching documents found.
Featured jobs
-
Digital Account Director
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Scientific Director – Medical Communications
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Health Consultant - Brand Comms
-
Competitive Salary
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
-
Account Director, Medical Education
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
- Senior Account Manager, Medical Communications, London
-
Excellent package
Subscribe to our email news alerts
- Fishawack acquires Dudnyk
- GSK’s myeloma drug hits target, prompting rapid filing pledge
- Winners of the HSJ Partnership Awards 2019 unveiled
- 50 questions for delivering an exceptional healthcare brand experience
- Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity
- The brand strategy revolution
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- 50 questions for delivering an exceptional healthcare brand experience
- Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
- The brand strategy revolution
- Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
